Global InformationGeoffrey von Maltzahn information
 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (June 2023) |
Geoffrey von Maltzahn | |
|---|---|
 | |
| Born | July 22, 1980 |
| Nationality | American |
| Alma mater | Massachusetts Institute of Technology (S.B.) University of California, San Diego (M.S.) Massachusetts Institute of Technology (Ph.D.) |
| Known for | Genome engineering, Bioengineering, Microbiome therapeutics, microbiome agriculture, communicating nanoparticles |
| Awards | Lemelson-MIT Student Prize (2009) National Inventors Hall of Fame Collegiate Inventors Competition Graduate Prize (2009), Massachusetts Institute of Technology Randolph G Wei Award (2003) |
| Scientific career | |
| Fields | Genome engineering, Bioengineering, Microbiome, Microbiology, Nanotechnology, Microbiome Agriculture, Synthetic Biology |
| Academic advisors | Sangeeta N. Bhatia, Shuguang Zhang |
Geoffrey von Maltzahn (born July 22, 1980) is an American biological engineer and businessman in the biotechnology and life sciences industry who has founded a number of companies including Indigo Agriculture, Sana Biotechnology, Kaleido Biosciences, Seres Therapeutics, Axcella Health, Generate Biomedicines and Tessera Therapeutics.[1][2][3] He has over 200 bioengineering and biotechnology patents and applications.[4][5][6][7]
- ^ Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine Business Insider Retrieved 9 October 2017
- ^ "Former Juno execs unveil Sana, a new cell engineering biotech that's reportedly raising more than $800M". GeekWire. January 7, 2019.
- ^ "This Company Wants to Rewrite the Future of Genetic Disease". Wired. July 7, 2020.
- ^ Patents by Inventor Geoffrey von Maltzahn Justia Patents
- ^ Patents as Early Indicators of Technology and Investment Trends Frontiers - figure 3 Retrieved 20 June 2018
- ^ Geoffrey von Maltzahn at Bloomberg Bloomberg
- ^ Flagship Pioneering Unveils Kaleido Biosciences and First Chemistry Platform for Microbiome Health Market Insider Retrieved 18 September 2017